Author(s): Sandeep Chandakavate, Shraddha Desai, Sharanagoud Biradar, Prashant Prajapati
Novel corona virus has emerged in 31 December 2019 namely as nCOV19. Currently, no promising drug is available to treat against SARS-CoV infection. In the present studies to understand the exhibited antiviral drugs used to treat COVID19. The study was investigated the antiviral drugs shown effective dose in the treatment of SAR-CoV-2 symptoms. Aim of study was to know available antiviral drug exhibit the efficacy and positive result against COVID-19 by in vivo, in vitro and virtual screening.